Form 4: Legend Biotech CEO Sells Shares

Legend Biotech Corp. CEO Ying Huang reported a sale of 5,566 ordinary shares on June 25, 2026, to cover tax obligations.

Summary

• Ying Huang, CEO and Director of Legend Biotech Corp., sold 5,566 ordinary shares on June 25, 2026.
• The sale was to satisfy withholding tax obligations upon the vesting of restricted share units.
• The shares were sold at a weighted average price of $14.78 per ordinary share, with individual sales ranging from $14.065 to $14.99 per ordinary share.
• Following the transaction, Huang beneficially owns 241,872 ordinary shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale is attributed to tax obligations rather than a negative outlook on the company.

Negatives

• CEO Ying Huang sold a portion of their holdings, reducing direct beneficial ownership.

Future Outlook

No specific future outlook or guidance is provided in this filing.

Industry Context

StockSavvy.ai notes that insider sales, particularly for tax withholding purposes, are common events and do not necessarily indicate a negative view of the company's prospects. The key is to monitor the volume and frequency of such sales.

Stakeholder Impact

• Shareholders: The sale reduces the number of shares directly held by the CEO, which could be perceived negatively if not for the stated tax withholding reason. The overall impact on share price is likely minimal given the nature of the transaction.

Key Dates

Keywords

Legend Biotech Corp, LEGN, Form 4, Insider Transaction, Share Sale, Ying Huang, CEO, Withholding Tax